نتایج جستجو برای: linear morphea

تعداد نتایج: 482724  

2010

Commentary Systemic sclerosis is one of the rheumatic diseases that is associated with the worst prognosis. Systemic sclerosis is divided into localized and systemic forms. Localized scleroderma comprises four subtypes, namely morphea, generalized morphea, linear scleroderma and en coup de saber, and is more commonly encountered in children. Although conversion into systemic sclerosis is very u...

2013
Sana Abourazzak Meryem Meziane Zahra Akodad Youssef Bouyahyaoui Mounia Idrissi Sana Chaouki Samir Atmani FZ Mernissi Afaf Amarti Moustapha Hida

Received: Jan 16, 2013 Accepted: Feb 13, 2013 Ann Paediatr Rheum 2013; 2:50-55 DOI: 10.5455/apr. 021320131602 Introduction Morphea or Localized scleroderma (LS) is an idiopathic inflammatory disease of the skin characterized by localized, circumscribed sclerotic patches, or plaques with variable pigmentation. LS has been differentiated from systemic sclerosis based upon the clinical findings of...

2013
Aleksandra Dańczak-Pazdrowska Michał J. Kowalczyk Beata Szramka-Pawlak Justyna Gornowicz-Porowska Aleksandra Szewczyk Wojciech Silny Marta Molińska-Glura Anna Olewicz-Gawlik Ryszard Żaba Jakub Pazdrowski Paweł Hrycaj

INTRODUCTION Morphea (localized scleroderma) is a rare cutaneous disease characterized by skin fibrosis of unknown pathogenesis. Transforming growth factor-β (TGF-β) is a potent profibrotic factor. The role of TGF-β in morphea remains unclear. AIM The goal of this study was to estimate the expression level of TGF-β1 in skin and peripheral blood mononuclear cells as well as the plasma levels o...

2017
Michał J. Kowalczyk Aleksandra Dańczak-Pazdrowska Beata Szramka-Pawlak Ryszard Żaba Agnieszka Osmola-Mańkowska Wojciech Silny

INTRODUCTION Morphea (localized scleroderma) is a relatively rare disease characterized by excessive skin fibrosis. Human endogenous retroviruses (HERV) are largely distributed within the human genome with hundreds of thousands of elements. The HERV have been widely studied in autoimmune disorders, yet hardly ever assessed in diseases with a good prognosis such as morphea. AIM In this study w...

Journal: :Annals of the rheumatic diseases 1981
R M Bernstein M A Hall B E Gostelow

We report the case of a 48-year-old woman who developed morphea-like plaques after 1 year of treatment with D-penicillamine at 250 mg daily for a seronegative erosive arthritis of rheumatoid type. The rash began as several red itchy patches on the trunk; these became thickened and shiny over about 3 months. The histological appearance was of increased dermal fibrosis with an inflammatory infilt...

2017
Stefano Caccavale Tobia Caccavale Maddalena La Montagna

Sir, We read with great interest the report recently published in the Indian Journal of Dermatology by Balegar et al.,[1] which describes a case of a 27-year-old male who developed radiation-induced progressive generalized morphea after getting radiotherapy (RT) for an intracranial tumor. In this patient, morphea, initially strictly localized on the irradiated zone, appeared some months after t...

2006
John Voorhees Edward B Lee Grant J Anhalt John J Voorhees Luis A Diaz

The term "scleroderma" traditionally has been uti l ized to describe the cutaneous changes of a heterogeneous group of disorders involving hardening, tightening, and decreased elasticity of the skin.' Two extreme forms have been identified-localized and diffuse. The localized form, specifically morphea, i s characterized by well-circumscribed, sclerotic plaques with an ivory-colored center and ...

ژورنال: :پوست و زیبایی 0
منصور نصیری کاشانی mansour nassiri-kashani center for research and training in skin diseases and leprosy, tehran university of medical sciencesمرکز آموزش و پژوهش بیماری های پوست و جذام، دانشگاه علوم پزشکی تهران، تهران، ایران شهاب باباکوهی shahab babakoohi center for research and training in skin diseases and leprosy, tehran university of medical sciencesمرکز آموزش و پژوهش بیماری های پوست و جذام، دانشگاه علوم پزشکی تهران، تهران، ایران علی کازرونی تیمسار ali kazerouni-timsar center for research and training in skin diseases and leprosy, tehran university of medical sciencesمرکز آموزش و پژوهش بیماری های پوست و جذام، دانشگاه علوم پزشکی تهران، تهران، ایران

این مقاله به معرفی بیمار 28 ساله ای با morphea profunda، درگیری عصب حسی ـ حرکتی محیطی، دیابت قندی وابسته به انسولین و هیپوتیروئیدی به عنوان تظاهر ناشایعی از مورفه آی عمقی می پردازد که پس از 4 ماه درمان با پردنیزولون و متوترکسات به صورت قابل توجهی بهبود یافت.تشخیص morphea profunda بر اساس کرایتریاهای بالینی، هیستوپاتولوژیک و درمانی صورت می گیرد و بررسی دقیق مورفه آ فراتر از پاتولوژی موضعی، ضروری...

Journal: :Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2002
Daniel Eisen Tina S Alster

INTRODUCTION The clinical presentation of morphea varies from localized plaques to generalized eruptions. Its cause remains unknown and medical treatments have often proved unsatisfactory. Studies have previously shown that improvement of hypertrophic scars and fibrotic skin can be achieved with the use of a 585 nm pulsed dye laser (PDL). METHODS A case of plaque-type morphea was treated with...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید